Literature DB >> 21396840

Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder.

Seth P Lerner1, Hao Liu, Meng-Fen Wu, Yngvil K Thomas, J Alfred Witjes.   

Abstract

OBJECTIVES: To understand the additional benefits of HAL compared with conventional cystoscopy at the patient level and to explore relationships of urine cytology and CIS.
METHODS: We reanalyzed pooled data from 3 phase III studies comparing hexaminolevulinate (HAL, Hexvix) fluorescence cystoscopy with white light (WL) cystoscopy for detecting CIS.
RESULTS: Of 551 patients, 174 had at least one CIS lesion detected by HAL, WL, or random biopsy. The CIS detection rate of HAL was 0.87 vs. 0.75 for WL (P = 0.006). By multivariate Poisson regression, female patients had fewer CIS lesions (P < 0.0001) while older patients (≥ 65) had a higher number of CIS lesions detected by HAL (P = 0.04). HAL was less likely to detect CIS in patients previously treated with chemotherapy or BCG (P = 0.01 and 0.03, respectively), after adjusting for age. CIS was unifocal in 44% and multifocal in 56%. Multifocal CIS was associated with positive cytology more frequently than unifocal (65% vs. 45%; P = 0.016) whereas a negative cytology was more frequently associated with unifocal CIS. Patients with positive urine cytology had twice as many CIS lesions detected by HAL as patients with negative urine cytology (P = 0.02).
CONCLUSIONS: HAL cystoscopy had a higher CIS detection rate than WL cystoscopy. The average number of CIS lesions detected was associated with baseline clinical characteristics. Cytology was positive more frequently in multifocal CIS suggesting that HAL may be particularly useful in this setting to optimize detection of the extent of CIS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396840     DOI: 10.1016/j.urolonc.2010.09.009

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  18 in total

1.  A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.

Authors:  Alberto Lapini; Andrea Minervini; Alberto Masala; Luigi Schips; Armin Pycha; Luca Cindolo; Riccardo Giannella; Thomas Martini; Gianni Vittori; Danilo Zani; Fania Bellomo; Sergio Cosciani Cunico
Journal:  Surg Endosc       Date:  2012-06-23       Impact factor: 4.584

Review 2.  Enhanced Endoscopy in Bladder Cancer.

Authors:  Shane Pearce; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2018-08-17       Impact factor: 3.092

Review 3.  What is new in non-muscle-invasive bladder cancer in 2016?

Authors:  Ashish M Kamat; Murat Bağcıoğlu; Emre Huri
Journal:  Turk J Urol       Date:  2017-03-01

Review 4.  Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancer.

Authors:  Puck Oude Elferink; J Alfred Witjes
Journal:  Ther Adv Urol       Date:  2014-02

Review 5.  Advances in imaging technologies in the evaluation of high-grade bladder cancer.

Authors:  Dimitar V Zlatev; Emanuela Altobelli; Joseph C Liao
Journal:  Urol Clin North Am       Date:  2015-02-28       Impact factor: 2.241

Review 6.  Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.

Authors:  Lily P H Yang
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

Review 7.  Intraoperative optical imaging and tissue interrogation during urologic surgery.

Authors:  Mark Hsu; Mohit Gupta; Li-Ming Su; Joseph C Liao
Journal:  Curr Opin Urol       Date:  2014-01       Impact factor: 2.309

8.  Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trials.

Authors:  Haichao Yuan; Jianguo Qiu; Liangren Liu; Shuo Zheng; Lu Yang; Zhenghua Liu; Chunxiao Pu; Jinhong Li; Qiang Wei; Ping Han
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

Review 9.  Fluorescence imaging in surgery.

Authors:  Ryan K Orosco; Roger Y Tsien; Quyen T Nguyen
Journal:  IEEE Rev Biomed Eng       Date:  2013-01-15

10.  A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.

Authors:  Joo Yong Lee; Kang Su Cho; Dong Hyuk Kang; Hae Do Jung; Jong Kyou Kwon; Cheol Kyu Oh; Won Sik Ham; Young Deuk Choi
Journal:  BMC Cancer       Date:  2015-08-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.